Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients
一项针对免疫性血小板减少症患者的多中心随机开放标签II期临床试验，研究了三种利妥昔单抗给药方案。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2014.110213
Zwaginga, Jaap J; van der Holt, Bronno; Te Boekhorst, Peter A; Biemond, Bart J; Levin, Mark-David; van der Griend, René; Brand, Anneke; Zweegman, Sonja; Pruijt, Hans F M; Novotny, Vera M J; Vreugdenhil, Art; de Groot, Marco R; de Weerdt, Okke; van Pampus, Elisabeth C M; van Maanen-Lamme, Tanja M; Wittebol, Shulamiet; Schipperus, Martin R; Silbermann, Matthijs H; Huijgens, Peter C; Luten, Marleen; Hollestein, Rene; Brakenhoff, Jan A C; Schrama, Jolanda G; Valster, Fransje A A; Velders, Gerjo A; Koene, Harry R
